Anthony Curro has joined Compumedics USA (El Paso, Texas), a division of Compumedics, as vice president of sales. Curro previously headed the market development group, Northeast region, at Guidant. Compumedics manufactures computer-based patient monitoring and diagnostic systems.

Gen-Probe (San Diego) reported that Larry Mimms, PhD, who the company said had spearheaded its entry into blood screening and oncology markets, has been promoted to executive vice president, R&D, effective June 20. Mimms replaces Jim Godsey, PhD, who is leaving Gen-Probe to join a Johnson & Johnson subsidiary. Mimms joined Gen-Probe in 1994 as director of R&D. Gen-Probe manufactures nucleic acid tests used to diagnose human diseases and screen donated human blood.

Eugene Seymour, MD, has joined Nanoviricides (West Haven, Connecticut) as CEO and chairman of the board. Seymour founded SDS, which makes the Hema-Strip rapid HIV antibody blood test, and a non-profit foundation that provided testing and training programs for health workers in Asia and Africa. He has also served as a consultant to the UN Global Program on AIDS. Most recently, he was director of strategic alliances at a medical education startup,, that was later acquired and is now named Nanoviricides, recently purchased by, is creating special-purpose nanomaterials for viral therapy.

John Jensen has joined Pacific Biometrics (Seattle) as controller. Pacific Biometrics provides specialized central laboratory and contract research services to support pharmaceutical and diagnostic manufacturers conducting human clinical trial research.